Psychable's Co-Founder and Chief Strategy Officer, Matt Zemon, shares details about the company's new "Buy One, Give One" ketamine-assisted therapy program.
Similar Posts
Introducing the BENZINGA Psychedelic Capital Event | A Psychedelic Investor’s Dream
Buy your tickets to the Benzinga Psychedelics Capital Conference on…
MindMed Delays Project Lucy & Compass Pathways Has a Challenged Patent
MindMed’s Project Lucy is Delayed and Compass Pathways Has a…
Psychedelics, Neuroscience & Big Pharma – Interview with Rob Barrow | MindMed
In this episode of Psychedelic Spotlight, Matt sits down with…
Psychedelic Spotlight Interview with Douglas K. Gordon
In this episode of the Psychedelic Spotlight podcast, we connect…